An in vitro diagnostic test kit for the detection of free prostate-specific antigen (F-PSA), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, P...
Manufactured by
China
CanAg Diagnostics (Fujirebio) is a global leader in in-vitro diagnostics and the world's largest manufacturer of tumor marker gold standards. The company provides detection products for most common solid tumors including gastrointestinal, squamous cell, liver, pancreatic, prostate, ovarian, skin, and lung cancers. All products are manufactured in ISO13485-certified facilities in Sweden and USA, supplying tumor marker antigens and antibodies to major international diagnostic manufacturers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ACON Laboratories, Inc.
United States · 1 relevant product
K.Bio Sciences Co., Ltd.
Thailand · 1 relevant product
Reagena Oy
Finland · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 5 relevant products
Diagnostics Biochem Canada Inc.
Canada · 3 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 1 relevant product
Boditech Med Inc.
South Korea · 2 relevant products
Berkeley Health Ltd
United Kingdom · 2 relevant products
Zybio Inc.
China · 1 relevant product
iPASY Technologies Kft
Hungary · 4 relevant products
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 91 closest product alternatives
ACON Laboratories, Inc. · United States
Foresight® EIA Kits provide enzyme immunoassay testing for qualitative detection of infectious disease markers, cancer antigens, and pregnancy hormones. These diagnostic kits are designed for clinical laboratories and point-of-care settings, offering reliable screening with proven accuracy for multiple analytes.
K.Bio Sciences Co., Ltd. · Thailand
Enzyme immunoassay test kits developed for clinical diagnostic applications. These assays provide reliable immunological detection across various medical testing scenarios.
Reagena Oy · Finland
Enzyme immunoassay tests for diagnostic purposes, part of Reagena's comprehensive product portfolio for detecting animal-borne infections.
Shenzhen Microprofit Biotech Co., Ltd · China
FIA-based quantitative test kit for PSA measurement in prostate health screening. Designed for point-of-care testing applications.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of free prostate specific antigen in human serum samples. The assay has an assay time of 75 minutes, a shelf stability of 18 months, and a sensitivity of 0.05 ng/mL. Reference: CAN-FPSA-4400.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A lateral flow immunoassay test kit for detection of prostate-specific antigen levels. This test aids in prostate health screening and early detection of abnormalities.
Boditech Med Inc. · South Korea
A diagnostic test reagent for screening prostate cancer, monitoring treatment effectiveness, assessing risk, and detecting recurrence.
Berkeley Health Ltd · United Kingdom
Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.
Zybio Inc. · China
Immunoassay for prostate-specific antigen measurement in prostate cancer screening. Provides quantitative measurement for clinical decision-making.
Berkeley Health Ltd · United Kingdom
Rapid self-test kit for prostate PSA screening enabling home-based detection and early identification of prostate health concerns. The test delivers accurate results comparable to clinical laboratory analysis with simple instructions and quick turnaround. ISO 13485:2016 certified in-vitro diagnostic device designed for patient convenience and accessibility.
iPASY Technologies Kft · Hungary
A non-invasive, urine-sample-based diagnostic kit for prostate cancer detection and risk assessment. The kit utilizes PSA N-glycosylation analysis to detect asparagine-linked carbohydrates of PSA, providing comprehensive clinical insights into prostate cancer-related alterations. It employs recombinant antibody technology to ensure selectivity and cost-effectiveness, and is designed for simplicity, requiring no specialized or highly skilled operator personnel. The diagnostic method significantly reduces false-positive rates compared to conventional serum PSA tests.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Immunofluorescence test kit for simultaneous detection of AFP, CEA, and total PSA biomarkers. Used for cancer screening and monitoring in clinical laboratories and point-of-care settings. Provides rapid quantitative results for liver, colorectal, and prostate cancer assessment.
79 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products